2Kramer U, Nevo Y, Neufel D, et al. Epidemiology of epilepsy in childhood: acohort of 440 consecutive patients[J]. Pediatr Neurol,1998,18:46.
3Trevathan E. Infantile spasm and LGS[J]. Child Neurol,2002, 17(suppl 2):S9- S22.
4Angehagen M, Ben-Menachem E, Ronnback L, et al. Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate[J]. Neurochem Res, 2003,28(2): 333-340.
5Lhatoo SD, Wong IC, Polizzi G, et al. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy[J]. Epilepsia, 2000,41(12): 1592-1596.
6Mikaeloff Y, de-Saint-Martin A, Mancini J, et al. Topiramate: efficacy and tolerability in children according to epilepsy syndromes[J]. Epilepsy Res,2003,53(3): 225-232.
7Dodson WE, Kamin M, Kraut L, et al. Topiramate titration to response: analysis of individualized therapy study (TRAITS)[J]. Ann Pharmacother,2003,37(5): 615-620.
8Mula M, Trimble MR, Thompson P, et al. Topiramate and word-finding difficulties in patients with epilepsy[J]. Neurology,2003,60(7): 1104-1107.
9Lee S, Sziklas V, Andermann F,et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy[J]. Epilepsia, 2003,44(3):339-347.
